import Link from "next/link";
import JsonLd from "@/components/JsonLd";

export const metadata = {
  alternates: { canonical: "/compare/epitalon-vs-nad-plus" },
  title: "Epitalon vs NAD+ — Longevity Supplement Comparison | Prof. Peptide",
  description: "Epitalon vs NAD+ comparison — how these two longevity compounds work, what the research shows, and how they differ in mechanism, evidence, and use.",
};

const rows = [
  ["Type", "Synthetic tetrapeptide (Ala-Glu-Asp-Gly)", "Coenzyme \u2014 supplemented via precursors NMN or NR"],
  ["Origin", "Derived from pineal gland peptide epithalamin \u2014 developed in Russia", "Natural coenzyme present in all living cells"],
  ["Primary Mechanism", "Telomerase (the enzyme that maintains telomere length) activation, epigenetic regulation (changes in gene expression without changing the underlying DNA), circadian rhythm restoration", "Sirtuin (a family of enzymes that regulate cellular aging and require NAD+ to function) activation, PARP (poly-ADP ribose polymerase \u2014 DNA repair enzymes that consume NAD+) activation, mitochondrial energy metabolism"],
  ["Key Benefit", "Telomere (protective caps at the ends of chromosomes that shorten with each cell division) lengthening \u2014 extends cellular replicative lifespan", "NAD+ restoration \u2014 reverses age-related metabolic decline"],
  ["Research Volume", "Primarily one Russian research group (Khavinson) \u2014 limited independent replication", "Large and growing international trial base"],
  ["Human Trial Quality", "Small studies \u2014 blood cell telomere length in elderly", "Multiple RCTs \u2014 NAD+ elevation consistently confirmed"],
  ["Independent Replication", "Limited \u2014 2025 UK study is first major independent confirmation", "Strong \u2014 multiple independent labs globally"],
  ["Pineal/Circadian Effects", "Restores melatonin secretion in aged animals and humans", "Not directly studied"],
  ["Regulatory Status", "Not FDA approved \u2014 research use", "Supplement (NMN regulatory status uncertain in US)"],
  ["Administration", "Injectable or oral", "Oral supplement (NMN or NR capsules)"],
  ["Cost", "$50\u2013200/course", "$30\u2013150/month ongoing"],
];

export default function EpitalonVsNADPage() {
  return (
    <>
      <JsonLd data={{"@context":"https://schema.org","@type":"Article","headline":"Epitalon vs NAD+ — Longevity Supplement Comparison","description":"Epitalon vs NAD+ comparison — how these two longevity compounds work, what the research shows, and how they differ in mechanism, evidence, and use.","url":"https://profpeptide.com/compare/epitalon-vs-nad-plus","publisher":{"@type":"Organization","name":"Prof. Peptide","url":"https://profpeptide.com"}}} />
      <JsonLd data={{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://profpeptide.com"},{"@type":"ListItem","position":2,"name":"Comparisons","item":"https://profpeptide.com/compare"},{"@type":"ListItem","position":3,"name":"Epitalon vs NAD+ — Longevity Supplement Comparison"}]}} />
    <div className="section max-w-4xl">
      <Link href="/compare" className="text-sm text-[#0891b2] hover:underline mb-6 inline-block">&larr; Back to Comparisons</Link>
      <h1 className="text-3xl font-bold text-[#1e2d3d] dark:text-slate-100 mb-3">Epitalon vs NAD+ &mdash; Longevity Compound Comparison</h1>
      <p className="text-sm text-gray-500 dark:text-slate-400 leading-relaxed mb-8 max-w-2xl">Epitalon and NAD+ are two of the most discussed compounds in longevity research &mdash; but they work through completely different mechanisms and have very different evidence bases. Epitalon is a research peptide targeting telomere biology. NAD+ (via NMN or NR) targets mitochondrial function and cellular energy metabolism.</p>

      <div className="mb-8 p-5 border border-[#0891b2]/20 bg-[#0891b2]/10 rounded-xl">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-3">Why these two compounds are not actually competitors</h2>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          Epitalon and NAD+ are both discussed in longevity research, but they target completely different aging mechanisms &mdash; making them complementary, not competing.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          Epitalon (a synthetic tetrapeptide developed in Russia) is studied primarily for telomere biology. Telomeres are protective caps at the ends of chromosomes that shorten each time a cell divides. When telomeres get critically short, the cell stops dividing or becomes senescent. Epitalon is hypothesized to activate telomerase &mdash; the enzyme that maintains telomere length. The Russian research (Khavinson group) reported telomere lengthening in human blood cells.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          NAD+ (and its precursors NMN and NR) target a different aging mechanism: mitochondrial function and cellular energy. NAD+ is required for sirtuin enzymes (which regulate cellular aging programs), PARP enzymes (DNA repair), and basic mitochondrial energy production. NAD+ levels decline ~50% by age 50.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed mb-3">
          Telomere length and NAD+ levels are independent aging metrics. A cell can have long telomeres but low NAD+ (energy-poor but replicatively young), or high NAD+ with short telomeres (energy-rich but near replicative limit). This is why some longevity protocols use both &mdash; they&apos;re targeting different problems.
        </p>
        <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
          The major caveat: Epitalon&apos;s evidence base is much narrower than NAD+&apos;s. Most Epitalon research comes from a single Russian research group, with limited independent replication globally. NAD+ research has dozens of independent labs running clinical trials. Evidence quality is the key reason mainstream longevity recommendations favor NAD+ precursors over Epitalon.
        </p>
      </div>

      <div className="overflow-x-auto mb-8">
        <table className="w-full text-sm border-collapse">
          <thead><tr className="bg-gray-50 dark:bg-[#1e293b]">
            <th className="text-left px-4 py-3 font-semibold text-gray-400 dark:text-slate-500 text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-1/4"></th>
            <th className="text-left px-4 py-3 font-semibold text-[#0891b2] text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-[37.5%]">Epitalon</th>
            <th className="text-left px-4 py-3 font-semibold text-[#0891b2] text-xs uppercase tracking-wider border-b border-gray-100 dark:border-slate-700 w-[37.5%]">NAD+ (via NMN/NR)</th>
          </tr></thead>
          <tbody>{rows.map(([label, a, b], i) => (
            <tr key={i} className={i % 2 === 0 ? "bg-white dark:bg-[#0f172a]" : "bg-gray-50/50 dark:bg-slate-800/50"}>
              <td className="px-4 py-3 font-medium text-[#1e2d3d] dark:text-slate-100 border-b border-gray-100 dark:border-slate-700">{label}</td>
              <td className="px-4 py-3 text-gray-600 dark:text-slate-300 border-b border-gray-100 dark:border-slate-700">{a}</td>
              <td className="px-4 py-3 text-gray-600 dark:text-slate-300 border-b border-gray-100 dark:border-slate-700">{b}</td>
            </tr>
          ))}</tbody>
        </table>
      </div>
      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Which one is right for you?</h2>
        <p className="text-sm text-gray-500 dark:text-slate-400 leading-relaxed mb-4">
          For most people interested in longevity, NAD+ precursors are the recommended starting point because of stronger evidence. Epitalon has interesting biology but a thinner research base.
        </p>
        <div className="space-y-4">
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Starting longevity research from scratch</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              NAD+ precursors (NMN or NR) are the rational entry point. Strong international research base, dozens of independent clinical trials, well-characterized safety profile, multiple mechanism studies. Epitalon is more speculative &mdash; interesting biology but most evidence concentrated in one research group.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Specific interest in telomere biology</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              If your primary research interest is telomere biology specifically, Epitalon is more directly relevant. Khavinson group studies (Russia, primarily) report blood cell telomere lengthening with cyclic dosing protocols. The 2025 UK study was the first major independent replication. Pair with TA-65 (another telomerase activator) for a telomere-focused stack.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Comprehensive longevity protocol — both make sense</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              They target different aging mechanisms (telomere length vs cellular energy/sirtuins). Some longevity protocols use both. Typical structure: ongoing daily NAD+ precursor (NMN or NR), plus a 10&ndash;20 day cycle of Epitalon every 6&ndash;12 months (matching the cyclic dosing in research). The combination addresses replicative aging AND metabolic aging.
            </p>
          </div>
          <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5">
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Cost-conscious approach</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Niacin is the cheapest NAD+ precursor by far ($5&ndash;15/month) and effective. Epitalon courses run $50&ndash;200 for a 10&ndash;20 day cycle, but the cycle is occasional (1&ndash;2x/year) rather than continuous. Total annual cost: niacin ~$120/year, Epitalon ~$200&ndash;400/year for cyclic dosing. Both fit reasonable budgets.
            </p>
          </div>
        </div>
      </div>

      <div className="border border-gray-100 dark:border-slate-700 rounded-xl p-5 mb-8">
        <h2 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-2">Bottom Line</h2>
        <p className="text-sm text-gray-600 dark:text-slate-300">NAD+ precursors have far more robust and independently replicated human evidence. <Link href="/peptides/epitalon" className="text-[#0891b2] hover:underline">Epitalon</Link> has fascinating telomere biology but the evidence base is narrow and concentrated in a single research group. They target entirely different aging mechanisms and could theoretically be studied together as part of a comprehensive longevity protocol.</p>
      </div>

      <div className="mb-8">
        <h2 className="text-lg font-semibold text-[#1e2d3d] dark:text-slate-100 mb-4">FAQ</h2>
        <div className="space-y-4">
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Is Epitalon actually proven to extend lifespan?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              In humans, no. The lifespan claims come from Russian animal studies (Khavinson group) showing extended median lifespan in mice. Human studies have shown telomere lengthening in blood cells and improvements in some biomarkers, but no controlled long-term human trial of Epitalon&apos;s effect on lifespan exists. The 2025 UK study independently replicated some of the telomere findings, which is significant. NAD+ precursors have similarly limited direct lifespan evidence in humans, though the biological case for NAD+ restoration is stronger.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Why is most Epitalon research in Russian?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Epitalon was developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology starting in the 1980s. Russian gerontology research operated somewhat independently from Western research during this period, and most of Epitalon&apos;s foundational studies were published in Russian-language journals. Translation and Western replication are still catching up. The 2025 UK study is part of that catch-up.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">How is Epitalon dosed?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Research protocols use cyclic injection: 5&ndash;10mg per day subcutaneous for 10&ndash;20 days, repeated every 6&ndash;12 months. Oral forms exist but bioavailability is poor (peptide breakdown in digestion). Most serious research uses injection. Epitalon is not FDA-approved and is sold as a research peptide.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Can I take Epitalon and NMN together?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Yes &mdash; they target different aging mechanisms with no documented interaction. Some longevity protocols use NMN daily (continuous) and Epitalon cyclically (10&ndash;20 days, twice yearly). Discuss with a knowledgeable practitioner before stacking research peptides with supplements.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">What&apos;s the risk profile of Epitalon?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              Russian research reports minimal side effects across decades of use. Most serious adverse events are not documented in published trials. Long-term safety in Western populations is essentially uncharacterized. The theoretical concern with telomerase activation is cancer risk &mdash; some cancers reactivate telomerase to enable unlimited division &mdash; but no cancer signal has emerged in available Epitalon human data.
            </p>
          </div>
          <div>
            <h3 className="text-sm font-semibold text-[#1e2d3d] dark:text-slate-100 mb-1">Why not just take NMN if I want longevity benefits?</h3>
            <p className="text-sm text-gray-600 dark:text-slate-300 leading-relaxed">
              For most people, that IS the recommended approach. NMN has stronger evidence, more international research, easier oral dosing, and a clearer regulatory pathway. Epitalon is more interesting if telomere biology specifically appeals to you, or if you want to address aging from multiple angles. For a single-supplement longevity approach, NMN (or NR or niacin) is rational. For multi-mechanism protocols, both can fit.
            </p>
          </div>
        </div>
      </div>

      <div className="flex gap-3 mb-8">
        <Link href="/peptides/epitalon" className="btn-primary text-sm">Epitalon Profile</Link>
        <Link href="/supplements/nad-plus" className="btn-outline text-sm">NAD+ Profile</Link>
        <Link href="/supplements/nmn" className="btn-outline text-sm">NMN Profile</Link>
      </div>
      <p className="text-xs text-gray-400 dark:text-slate-500">For educational and research purposes only. Not medical advice.</p>
    </div>
    </>
  );
}
